Merck, Foundation Medicine to Develop Companion Diagnostics for Immunotherapy – GenomeWeb
|
Merck, Foundation Medicine to Develop Companion Diagnostics for Immunotherapy
GenomeWeb NEW YORK (GenomeWeb) – Foundation Medicine has inked a collaboration with Merck to develop companion diagnostic tests for use with Merck's anti-PD-1 immunotherapy drug Keytruda (pembrolizumab). Under the agreement announced today, the … |
